1. Gravallese ME, Baker N, Lester S, Kay J, et al. Musculoskeletal manifestations in (32 microglobulin amyloidosis. Arthritis and Rheum 1992; 35 (5): 592-602.
2. Goodman WG, Coburn JW, et al. Renal osteodystrophy in adults and children. In: Favus MJ (Ed), Primer on the Meta¬bolic Bone Diseases and Disorders of Mineral Metabolism. Lippincott-Raven/Philadelphia. 1999; pp 347-363.
3. Reginato AJ, Ferreiro SJL, Barbazan AC, Mitja P, et al. Arth-ropathy and cutaneus calcinosis in hemodialysis oxalosis. Arthritis Rheum 1986; 29 (11): 1387-1396.
4. Menerey K, Braunstein E, Brown M, Swartz R, et al. Muscu-loskeletal symptoms related to arthropathy in patients rece¬iving dialysis. J Rheumatol 1988; 15(12): 1848-1854.
5. Cornelis F, Bardin T, Faller B, Verger C, et al. Rheumatic syndromes and beta 2-microglobulin amyloidosis in pati¬ents receiving long term peritoneal dialysis. Arthritis Rheum
1989; 32 (6): 785-788.
6. Warren DJ, Otieno LS. Carpal tunnel syndrome in patients on intermittent haemodialysis. Post Grad Med J 1975; 51:
450-452.
7. Chatopantyay C, Ackrill D, Clague RB. The shoulder pain syndrome and soft tissue abnormalities in patients on long term haemodialysis. Br J Rheumatol 1987; 26: 181-187.
8. Drüeke TA. (32 Microglobulin and amyloidosis. Nephrol Dial Transplant 2000-15 (suppl:1):17-24.
9. Bardin T, Zingraff J, Kuntz D, Drüeke T. Dialysis related amyloidosis. Nephrol Dial Transplant 1986;1: 151-154.
10. Van Ypersale, Strihou C, Honhon B, Vandenbroucke JM, Hauaux JP, Noel H, Maldague B. Dialysis amyloidosis. Adv
Nephrol 1988;17:401-420.
11. Gejyo F. Beta-2microglobulin and dialysis-related amyloido-
sis. Rinsho Byori 2001 Mar;49(3):244-8.
12. Niwa T. Dialysis-related amyloidosis: pathogenesis focusing
on AGE modification. Semin Dial 2001 Mar-Apr;14(2):123-6.
13. Jadoul M, Garbar C, Noel H, et al. Histological prevalence of (32 microglobulin amyloidosis in hemodialysis: a pros-
58
Türk
Nefroloj
i Diyaliz ve Transplantasyon Dergisi /Official Journal of the Turkish Society of Nephrology
fS2 Mikroglobülin Birikimi ve Vasküler Çalma Sendromu Zemininde Gelişen Karpal Tünel Sendromu: Bir Olgu Sunumu O
pective postmortem study. Kidney Int 1997;51: 1928-1932.
14. Zingraf J, Noel LH, Bardin T, et al. Beta-2 microglobulin amyloidosis in chronic renal failure. N Engl J Med
1990;323:1070-1071 (Letter).
15. Moriniere P, Marie A, Esper NE, et al. Destructive spondy-larthropathy with (2 microglobulin deposits in uremic pati¬ent before chronic hemodialysis. Nephron 1991; 59:654-657.
16. Gejyo F, Narita I. Current clinical and pathogenetic unders¬tanding of beta2-m amyloidosis in long-term haemodialysis
patients. Nephrology (Carlton) 2003 Oct;8 Suppl:S45-9.
17. Allieu Y, Chammas M, Idoux O, Hixson M, et al. Carpal tun¬nel syndrome and amyloid tenosynovitis in patients under¬going chronic hemodialysis. Evaluation and treatment apro¬pos of 130 cases. Ann Chir Main Memb Super 1994; 13(2):
113-121
18. Locatelli F, Manzoni C, Pozzoni P, Pontoriero G, Di Filippo L. Clinical dialysis: new problems and new prospects. G Ital Nefrol 2004 Mar-Apr;21(2):156-64.
19. Dzido G, Sprague SM. Dialysis-related amyloidosis. Minerva
Urol Nefrol 2003 Jun;55(2):121-9.
Thank you for copying data from http://www.arastirmax.com